07 February 2025 : Clinical Research
Impact of Osteopathic Techniques on Autonomic Regulation: A Study of Heart Rate Variability in Healthy Adults
Jakub Stępnik ABCDEFG 1,2*, Agnieszka Kędra
DE 3, Dariusz Czaprowski AE 4,5
DOI: 10.12659/MSM.946903
Med Sci Monit 2025; 31:e946903
Table 6 Results of the analysis of variance for the LF parameter.
| Factor RM 1 | Group | M | SE | 95% confidence interval | ANOVA | |
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | |||||
| LF I | CV4 | 42.8 | 3.10 | 36.7 | 49.0 | F1=(2,194)=0.961;p=0.358; eta2=0.004 |
| CV4+RR | 52.2 B | 3.15 | 45.9 | 58.4 | ||
| Placebo | 43.0 | 3.15 | 36.8 | 49.3 | ||
| LF II | CV4 | 38.1 a | 2.94 | 32.2 | 43.9 | F2=(4,194)=3.79;p=0.005; eta2=0.030 |
| CV4+RR | 64.0 B,a,b | 2.99 | 58.1 | 70.0 | ||
| Placebo | 42.0 b | 2.99 | 36.0 | 47.9 | ||
| LF III | CV4 | 37.8 a | 2.92 | 32.0 | 43.6 | F3=(2,97)=16;p<0.001; eta2=0.167 |
| CV4+RR | 55.5 a | 2.97 | 49.7 | 61.4 | ||
| Placebo | 43.3 | 2.97 | 37.4 | 49.2 | ||
| M – mean; SE – standard error; F1 – main effect of the LF parameter; F2 – interaction effect between changes in LF measurements and group; F3 – main effect of group; p – level of significance; eta – effect size; a,b – significant differences between groups in a given measurement; B – significant differences within a group between measurements. | ||||||